Metastatic Breast Cancer, Triple Negative Breast Cancer Not Yet Recruiting Phase 2 Trials for Carboplatin (DB00958)

Also known as: Metastatic Triple-negative Breast Cancer / Metastatic Triple Negative Breast Cancer / Triple-negative Metastatic Breast Cancer / Triple Negative Metastatic Breast Cancer

DBCOND0074793 (Metastatic Breast Cancer, Triple Negative Breast Cancer)Not Yet Recruiting2 IdentifierTitlePurposeDrugs
NCT04739670Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast CancerTreatment